Journal Article
. 2021 Aug; 10(1):1962592.
doi: 10.1080/2162402X.2021.1962592.

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells

Takahiro Yamazaki 1 Erik Wennerberg 1 Michal Hensler 2 Aitziber Buqué 1 Jeffrey Kraynak 1 Jitka Fucikova 2 Xi Kathy Zhou 3 Baldur Sveinbjørnsson 4 Øystein Rekdal 4 Sandra Demaria 1 Lorenzo Galluzzi 1 
  • PMID: 34408925
  •     53 References
  •     3 citations


LTX-315 is a nonameric oncolytic peptide in early clinical development for the treatment of solid malignancies. Preclinical and clinical evidence indicates that the anticancer properties of LTX-315 originate not only from its ability to selectively kill cancer cells, but also from its capacity to promote tumor-targeting immune responses. Here, we investigated the therapeutic activity and immunological correlates of intratumoral LTX-315 administration in three syngeneic mouse models of breast carcinoma, with a focus on the identification of possible combinatorial partners. We found that breast cancer control by LTX-315 is accompanied by a reconfiguration of the immunological tumor microenvironment that supports the activation of anticancer immunity and can be boosted by radiation therapy. Mechanistically, depletion of natural killer (NK) cells compromised the capacity of LTX-315 to limit local and systemic disease progression in a mouse model of triple-negative breast cancer, and to extend the survival of mice bearing hormone-accelerated, carcinogen-driven endogenous mammary carcinomas. Altogether, our data suggest that LTX-315 controls breast cancer progression by engaging NK cell-dependent immunity.

Keywords: CTLA4; MPA/DMBA-driven mammary carcinomas; PD-1; TS/A cells; cDC1s; immune checkpoint inhibitors.

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, +51 authors, Francesco M Marincola.
J Immunother Cancer, 2020 Mar 27; 8(1). PMID: 32209603    Free PMC article.
Exploring the NK cell platform for cancer immunotherapy.
Jacob A Myers, Jeffrey S Miller.
Nat Rev Clin Oncol, 2020 Sep 17; 18(2). PMID: 32934330    Free PMC article.
Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report.
Nina Louise Jebsen, Torunn Oveland Apelseth, +4 authors, Dag Eirik Jøssang.
J Med Case Rep, 2019 Jun 11; 13(1). PMID: 31177991    Free PMC article.
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
Michael I Love, Wolfgang Huber, Simon Anders.
Genome Biol, 2014 Dec 18; 15(12). PMID: 25516281    Free PMC article.
Highly Cited.
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Aitziber Buqué, Norma Bloy, +27 authors, Lorenzo Galluzzi.
Nat Commun, 2020 Aug 01; 11(1). PMID: 32732875    Free PMC article.
Immature T cells in peripheral lymphoid organs of recombinase-activating gene-1/-2-deficient mice. Thymus dependence and responsiveness to anti-CD3 epsilon antibody.
I Falk, A J Potocnik, +2 authors, K Eichmann.
J Immunol, 1996 Feb 15; 156(4). PMID: 8568235
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.
Karsten A Pilones, Michal Hensler, +5 authors, Silvia C Formenti.
Oncoimmunology, 2020 Nov 06; 9(1). PMID: 33150045    Free PMC article.
The oncolytic peptide LTX-315 triggers immunogenic cell death.
H Zhou, S Forveille, +11 authors, G Kroemer.
Cell Death Dis, 2016 Mar 11; 7. PMID: 26962684    Free PMC article.
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
Claire Vanpouille-Box, Amandine Alard, +7 authors, Sandra Demaria.
Nat Commun, 2017 Jun 10; 8. PMID: 28598415    Free PMC article.
Highly Cited.
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.
Etienne Becht, Nicolas A Giraldo, +8 authors, Aurélien de Reyniès.
Genome Biol, 2016 Oct 22; 17(1). PMID: 27765066    Free PMC article.
Highly Cited.
The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade.
T Yamazaki, J M Pitt, +5 authors, L Zitvogel.
Cell Death Differ, 2016 Apr 16; 23(6). PMID: 27082453    Free PMC article.
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.
Maria Esperanza Rodriguez-Ruiz, Ilio Vitale, +2 authors, Lorenzo Galluzzi.
Nat Immunol, 2019 Dec 25; 21(2). PMID: 31873291
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.
C J Aslakson, F R Miller.
Cancer Res, 1992 Mar 15; 52(6). PMID: 1540948
Highly Cited.
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
Suzanne I S Mosely, John E Prime, +21 authors, Robert W Wilkinson.
Cancer Immunol Res, 2016 Dec 08; 5(1). PMID: 27923825
Highly Cited.
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
Jan P Böttcher, Eduardo Bonavita, +7 authors, Caetano Reis e Sousa.
Cell, 2018 Feb 13; 172(5). PMID: 29429633    Free PMC article.
Highly Cited.
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA.
Leticia Corrales, Seng-Ryong Woo, +3 authors, Thomas F Gajewski.
J Immunol, 2016 Mar 02; 196(7). PMID: 26927800    Free PMC article.
Breast Cancer Immunotherapy: Facts and Hopes.
Leisha A Emens.
Clin Cancer Res, 2017 Aug 13; 24(3). PMID: 28801472    Free PMC article.
Highly Cited. Review.
Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
Ketil André Camilio, Gerd Berge, +2 authors, Baldur Sveinbjørnsson.
Cancer Immunol Immunother, 2014 Mar 29; 63(6). PMID: 24676901    Free PMC article.
Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi.
Nat Med, 2021 Feb 13; 27(2). PMID: 33574607
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.
Yang Liao, Gordon K Smyth, Wei Shi.
Bioinformatics, 2013 Nov 15; 30(7). PMID: 24227677
Highly Cited.
Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Hope S Rugo, Jean-Pierre Delord, +13 authors, Antoinette R Tan.
Clin Cancer Res, 2018 Mar 22; 24(12). PMID: 29559561
Highly Cited.
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer.
Giulia Petroni, Aitziber Buqué, +5 authors, Lorenzo Galluzzi.
Clin Cancer Res, 2021 Jan 27; 27(7). PMID: 33495311    Free PMC article.
NK cells beat T cells at early breast cancer control.
Aitziber Buque, Norma Bloy, +2 authors, Lorenzo Galluzzi.
Oncoimmunology, 2020 Sep 15; 9(1). PMID: 32923169    Free PMC article.
clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He.
OMICS, 2012 Mar 30; 16(5). PMID: 22455463    Free PMC article.
Highly Cited.
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.
James Spicer, Aurélien Marabelle, +18 authors, Øystein Rekdal.
Clin Cancer Res, 2021 Feb 06; 27(10). PMID: 33542073
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
Johanna Bödder, Tasmin Zahan, +3 authors, Georgina Flórez-Grau.
Front Immunol, 2021 Mar 09; 11. PMID: 33679726    Free PMC article.
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses.
Joyce Wei, Welby Montalvo-Ortiz, +7 authors, Dimitris Skokos.
Sci Immunol, 2021 Apr 11; 6(58). PMID: 33837124
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies.
Oliver Kepp, Aurelien Marabelle, Laurence Zitvogel, Guido Kroemer.
Nat Rev Clin Oncol, 2019 Oct 09; 17(1). PMID: 31595049
Cancer Immunosurveillance by T Cells.
Samhita Rao, Karim Gharib, Arnold Han.
Int Rev Cell Mol Biol, 2019 Jan 13; 342. PMID: 30635090
Complex heatmaps reveal patterns and correlations in multidimensional genomic data.
Zuguang Gu, Roland Eils, Matthias Schlesner.
Bioinformatics, 2016 May 22; 32(18). PMID: 27207943
Highly Cited.
Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents.
Giulia Petroni, Lorenzo Galluzzi.
Oncoimmunology, 2021 Mar 05; 10(1). PMID: 33659100    Free PMC article.
The NKG2A immune checkpoint - a new direction in cancer immunotherapy.
Benjamin C Creelan, Scott J Antonia.
Nat Rev Clin Oncol, 2019 Mar 03; 16(5). PMID: 30824813
Memory-like natural killer cells for cancer immunotherapy.
Margery Gang, Pamela Wong, Melissa M Berrien-Elliott, Todd A Fehniger.
Semin Hematol, 2020 Dec 02; 57(4). PMID: 33256911    Free PMC article.
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody.
M Zahidunnabi Dewan, Ashley E Galloway, +4 authors, Sandra Demaria.
Clin Cancer Res, 2009 Aug 27; 15(17). PMID: 19706802    Free PMC article.
Highly Cited.
Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Karsten A Pilones, Maud Charpentier, +5 authors, Sandra Demaria.
Cancer Immunol Res, 2020 Jun 14; 8(8). PMID: 32532811    Free PMC article.
NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo.
Hideto Nishikado, Kaori Mukai, +2 authors, Hajime Karasuyama.
J Immunol, 2011 Apr 15; 186(10). PMID: 21490162
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients.
Maria Esperanza Rodriguez-Ruiz, Aitziber Buqué, +7 authors, Lorenzo Galluzzi.
Oncoimmunology, 2019 Oct 28; 8(11). PMID: 31646105    Free PMC article.
Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model.
Ketil A Camilio, Meng-Yu Wang, +5 authors, Gunhild M Mælandsmo.
Breast Cancer Res, 2019 Jan 24; 21(1). PMID: 30670061    Free PMC article.
DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
Martín C Abba, Yi Zhong, +7 authors, C Marcelo Aldaz.
Oncotarget, 2016 Sep 03; 7(39). PMID: 27588403    Free PMC article.
The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.
Tania Løve Aaes, Peter Vandenabeele.
Cell Death Differ, 2020 Nov 21; 28(3). PMID: 33214663    Free PMC article.
Type I interferons and endoplasmic reticulum stress in health and disease.
Jenny Sprooten, Abhishek D Garg.
Int Rev Cell Mol Biol, 2020 Mar 07; 350. PMID: 32138904    Free PMC article.
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model.
Carla De Giovanni, Giordano Nicoletti, +3 authors, Patrizia Nanni.
Cancers (Basel), 2019 Dec 01; 11(12). PMID: 31783695    Free PMC article.
NK cell memory: discovery of a mystery.
Ulrich H von Andrian.
Nat Immunol, 2021 Apr 17; 22(6). PMID: 33859406
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
Michal Hensler, Lenka Kasikova, +22 authors, Jitka Fucikova.
J Immunother Cancer, 2020 Aug 21; 8(2). PMID: 32819974    Free PMC article.
The NLRP3 inflammasome: molecular activation and regulation to therapeutics.
Karen V Swanson, Meng Deng, Jenny P-Y Ting.
Nat Rev Immunol, 2019 May 01; 19(8). PMID: 31036962    Free PMC article.
Highly Cited. Review.
STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, +6 authors, Thomas R Gingeras.
Bioinformatics, 2012 Oct 30; 29(1). PMID: 23104886    Free PMC article.
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.
Florent Petitprez, Sacha Levy, +10 authors, Aurélien de Reyniès.
Genome Med, 2020 Oct 08; 12(1). PMID: 33023656    Free PMC article.
Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives.
L de la Cruz-Merino, M Chiesa, +4 authors, V Sánchez-Margalet.
Int Rev Cell Mol Biol, 2017 Mar 23; 331. PMID: 28325210
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides.
Ilio Vitale, Takahiro Yamazaki, +4 authors, Lorenzo Galluzzi.
Trends Cancer, 2021 Jan 16; 7(6). PMID: 33446447
The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.
Liv-Marie Eike, Nannan Yang, Øystein Rekdal, Baldur Sveinbjørnsson.
Oncotarget, 2015 Oct 17; 6(33). PMID: 26472184    Free PMC article.
CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.
E Assarsson, T Kambayashi, +5 authors, B J Chambers.
J Immunol, 2000 Oct 18; 165(7). PMID: 11034371
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Takahiro Yamazaki, Alexander Kirchmair, +12 authors, Lorenzo Galluzzi.
Nat Immunol, 2020 Aug 05; 21(10). PMID: 32747819
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment.
Giulia Petroni, Aitziber Buqué, Lisa M Coussens, Lorenzo Galluzzi.
Nat Rev Drug Discov, 2022 Mar 17; 21(6). PMID: 35292771
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis.
Tianyu Tang, Xing Huang, +6 authors, Tingbo Liang.
J Immunother Cancer, 2022 Mar 16; 10(3). PMID: 35288467    Free PMC article.
Immunogenic stress induced by local anesthetics injected into neoplastic lesions.
Lucillia Bezu, Oliver Kepp, Guido Kroemer.
Oncoimmunology, 2022 May 24; 11(1). PMID: 35602288    Free PMC article.